Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world study

Key Points

• This research aims to assess the long-term effectiveness and safety of the atezolizumab-bevacizumab combination in treating unresectable hepatocellular carcinoma.
• Conducted a real-world study
• Monitored effectiveness and safety of atezolizumab-bevacizumab
• Evaluated use of surgical and locoregional treatments
• Assessed liver decompensation events
• Confirmed sustained effectiveness of atezolizumab-bevacizumab treatment
• No new safety concerns reported
• High rates of surgical and locoregional treatments observed after starting therapy